Overview

A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This research is studying the effect that Resolvine injection will have on patients with vitreomacular adhesion.
Phase:
Phase 1
Details
Lead Sponsor:
Jeffrey S Heier
Collaborator:
Kato Pharmaceuticals, Inc.